FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Taro Pharmaceuticals U.S.A. Children's Ibuprofen Oral Suspension Recall

Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alco…

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class II
Reported by FDA
Nov 6, 2019
Recall ID
D-0302-2020
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Children's Ibuprofen Oral Suspension starting Sep 27, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0302-2020 on Nov 6, 2019. Reason: Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Product description

Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz.(120 mL), Distributed by: Winco Foods, LLC, Boise, ID 83704, NDC 67091-321-04

Lot numbers, UPCs & expiration codes

Lot #: A972834374, Exp 12/20

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0302-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 27, 2019
FDA report date
Nov 6, 2019
Quantity
5,280 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-0302-2020, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
83887
Address
3 Skyline Dr
Code information
Lot #: A972834374, Exp 12/20
Postal code
10532-2174
Report date
Nov 6, 2019
Product type
Drugs
Recall number
D-0302-2020
Classification
Class II
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
5,280 bottles
Termination date
Aug 31, 2023
Reason for recall
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz.(120 mL), Distributed by: Winco Foods, LLC, Boise, ID 83704, NDC 67091-321-04
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Sep 27, 2019
Initial firm notification
Letter
Center classification date
Nov 5, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0302-2020, published Nov 6, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls